THE WHAT? Kenvue has reported first-quarter 2026 gross sales and earnings development, supported by improved execution, innovation and margin enlargement throughout its well being and sweetness portfolio.
THE DETAILS Kenvue reported a 4.5% enhance in web gross sales for Q1 2026, with natural gross sales rising 0.7% and diluted earnings per share rising 47% to US$0.25. Adjusted diluted EPS rose 33% to US$0.32. The corporate stated enhancements in gross revenue and working margins have been pushed by provide chain optimization initiatives, productiveness good points and value discount programmes. Pores and skin Well being and Magnificence delivered the strongest efficiency, with web gross sales rising 8.4% and natural gross sales up 5%, supported by improvements together with Neutrogena Solar Care enlargement in EMEA and the launch of OGX Professional Development. Important Well being gross sales rose 4.9%, pushed by development in Child Care, Oral Care and Wound Care, whereas Self Care gross sales elevated 1.9% regardless of weaker chilly and flu seasons in main markets. Kenvue additionally confirmed progress on its deliberate acquisition by Kimberly-Clark, which is predicted to shut within the second half of 2026 pending regulatory approvals.
THE WHY? The outcomes exhibit continued resilience within the well being, magnificence and private care sector regardless of macroeconomic uncertainty, whereas highlighting Kenvue’s concentrate on operational efficiencies, innovation and portfolio strengthening forward of its merger with Kimberly-Clark.
Supply: Kenvue
